Insider · CIK 0001078452

Engler Robert

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001078452

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2014-08-14	HALOHALOZYME THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+75K sh	$2.05	+$154K	308,176
2014-08-14	HALOHALOZYME THERAPEUTICS, INC.S Sale	Director	SSale	−35K sh	$9.96	−$349K	273,176
2014-08-14	HALOHALOZYME THERAPEUTICS, INC. · Options to Purchase Common StockM Exercise/Conversion	Director	MExercise/Conversion	−75K sh	$2.05	−$154K	0
2013-05-16	HALOHALOZYME THERAPEUTICS, INC.A Award	Director	AAward	+20K sh	—	—	185,000
2012-11-29	HALOHALOZYME THERAPEUTICS, INC.P Purchase	Director	PPurchase	+15K sh	$5.57	+$83.6K	165,000
2012-05-03	HALOHALOZYME THERAPEUTICS, INC.A Award	Director	AAward	+20K sh	—	—	150,000
2011-11-14	HALOHALOZYME THERAPEUTICS, INC.P Purchase	Director	PPurchase	+5,000 sh	$8.15	+$40.8K	130,000
2011-05-05	HALOHALOZYME THERAPEUTICS, INC.A Award	Director	AAward	+20K sh	$0.00	+$20	125,000
2010-05-06	HALOHALOZYME THERAPEUTICS, INC.A Award	Director	AAward	+20K sh	$0.00	+$20	105,000
2009-05-07	HALOHALOZYME THERAPEUTICS, INC.A Award	Director	AAward	+20K sh	$0.00	+$20	85,000
2005-05-24	HALOHALOZYME THERAPEUTICS, INC.P Purchase	Director	PPurchase	+2,000 sh	$1.93	+$3,860	12,000
2005-05-24	HALOHALOZYME THERAPEUTICS, INC.P Purchase	Director	PPurchase	+12K sh	$1.93	+$23.2K	24,000
2005-05-24	HALOHALOZYME THERAPEUTICS, INC.P Purchase	Director	PPurchase	+1,400 sh	$1.97	+$2,758	25,400
2005-05-24	HALOHALOZYME THERAPEUTICS, INC.P Purchase	Director	PPurchase	+2,600 sh	$1.98	+$5,148	28,000
2005-05-24	HALOHALOZYME THERAPEUTICS, INC.P Purchase	Director	PPurchase	+7,000 sh	$1.99	+$13.9K	35,000
2004-10-13	HALOHALOZYME THERAPEUTICS, INC. · Options to Purchase Common StockA Award	Director	AAward	+75K sh	$2.05	+$154K	75,000
2004-08-18	HALOHALOZYME THERAPEUTICS, INC.P Purchase	Director	PPurchase	+10K sh	$1.60	+$16K	10,000
2004-05-21	HALOHALOZYME THERAPEUTICS, INC. · Options to Purchase Common StockA Award	Director	AAward	+150K sh	$4.10	+$615K	150,000

Recent filings

Accepted (ET)
Aug 184
HALOZYME THERAPEUTICS INC0001159036-14-000074
SEC(opens sec.gov)
May 164
Engler Robert0001483813-13-000059
SEC(opens sec.gov)
Nov 294
Engler Robert0001483813-12-000035
SEC(opens sec.gov)
May 44
Engler Robert0001483813-12-000010
SEC(opens sec.gov)
Nov 154
Engler Robert0001483813-11-000022
SEC(opens sec.gov)
May 64
Engler Robert0001209191-11-026696
SEC(opens sec.gov)
May 64
Engler Robert0001483813-10-000003
SEC(opens sec.gov)
May 84
Engler Robert0001462354-09-000010
SEC(opens sec.gov)
May 254
HALOZYME THERAPEUTICS INC0001181431-05-030403
SEC(opens sec.gov)
Feb 85
HALOZYME THERAPEUTICS INC0001181431-05-007924
SEC(opens sec.gov)
Aug 184
HALOZYME THERAPEUTICS INC0001209191-04-041398
SEC(opens sec.gov)

Companies

HALOZYME THERAPEUTICS, INC.DirectorHALO

Address

C/O HALOZYME THERAPEUTICS, INC. 11388 SORRENTO VALLEY ROAD

SAN DIEGO, CA, 92121